US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% META $741.90 ▲+1.90%
FinancialContent

Teleflex Incorporated Common Stock (NY:TFX)

125.24 +1.12 (+0.90%)
Official Closing Price Updated: 7:00 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Teleflex Incorporated Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
News headline image
3 Healthcare Stocks That Concern Us
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have be... 
Via StockStory
News headline image
Stocks making big moves yesterday: TTM Technologies, PacBio, Nvidia, Palo Alto Networks, and Teleflex
Check out the companies making headlines yesterday: PacBio (NASDAQ:PACB): Genomics company Pacific Biosciences of California (NASDAQ:PACB) rose by 5.8% on Mo... 
Via StockStory
News headline image
Teleflex Announces Latest Peer-Reviewed Study Demonstrates a Significant Reduction in CLABSI Risk with Arrowg+ard™ Technology
From Teleflex Incorporated
Via Business Wire
News headline image
Why Teleflex (TFX) Stock Is Trading Up Today
What Happened? Shares of medical technology company Teleflex (NYSE:TFX) jumped 4.5% in the afternoon session after BofA Securities upgraded the stock from Ne... 
Via StockStory
Topics Artificial Intelligence
News headline image
3 Reasons to Avoid TFX and 1 Stock to Buy Instead
Even though Teleflex (currently trading at $122.08 per share) has gained 6.2% over the last six months, it has lagged the S&P 500’s 21.4% return during that ... 
Via StockStory
Topics Stocks
News headline image
Surgical Equipment & Consumables - Specialty Stocks Q2 Earnings Review: Teleflex (NYSE:TFX) Shines
Looking back on surgical equipment & consumables - specialty stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Teleflex (NY... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of Directors
From Teleflex Incorporated
Via Business Wire
News headline image
Teleflex Features Innovative Dynetic™-35 Balloon-Expandable Cobalt Chromium Stent System at CIRSE 2026
From Teleflex Incorporated
Via Business Wire
News headline image
3 Unprofitable Stocks with Open Questions
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th... 
Via StockStory
News headline image
Teleflex (TFX) Q2 2026 Earnings Call Transcript ↗
CEO Weidman discusses integration delays, FDA approvals, and capital allocation strategy. 
Via The Motley Fool
Topics Earnings World Trade
News headline image
Teleflex’s Q2 Earnings Call: Our Top 5 Analyst Questions
Teleflex’s second quarter was marked by revenue and non-GAAP earnings per share above Wall Street expectations, yet the operating margin declined significant... 
Via StockStory
Topics Earnings
News headline image
1 Small-Cap Stock with Competitive Advantages and 2 We Brush Off
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ... 
Via StockStory
News headline image
Teleflex Q2 Earnings Call Highlights ↗
Teleflex (NYSE:TFX) reported second-quarter revenue and adjusted earnings above its expectations, supported by strong growth in its Vascular and Surgical businesses, while slower-than-anticipated... 
Via MarketBeat
Topics Earnings
News headline image
Teleflex (NYSE:TFX) Exceeds Q2 CY2026 Expectations
Medical technology company Teleflex (NYSE:TFX) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 28.9% year on year to $5... 
Via StockStory
News headline image
Teleflex Announces Quarterly Dividend
From Teleflex Incorporated
Via Business Wire
News headline image
Teleflex Reports Second Quarter Financial Results and Full Year 2026 Outlook
From Teleflex Incorporated
Via Business Wire
News headline image
Teleflex (TFX) Q2 Earnings Report Preview: What To Look For
Medical technology company Teleflex (NYSE:TFX) will be reporting earnings this Thursday morning. Here’s what to expect. Teleflex beat analysts’ revenue expec... 
Via StockStory
News headline image
Teleflex Medical OEM Launches as INGENYX to Empower Tomorrow’s MedTech Innovators
From INGENYX
Via GlobeNewswire
News headline image
Teleflex Completes Strategic Divestiture of OEM Business for $1.5 Billion
From Teleflex Incorporated
Via Business Wire
News headline image
Teleflex Announces FDA BLA Approval of EZPLAZ™ Freeze Dried Plasma
From Teleflex Incorporated
Via Business Wire
News headline image
Teleflex Announces Second Quarter 2026 Earnings Conference Call Information
From Teleflex Incorporated
Via Business Wire
News headline image
Teleflex Awarded National Central Venous Access Agreement with Premier, Inc.
From Teleflex Incorporated
Via Business Wire
News headline image
Teleflex Publishes 2025 Global Impact Report
From Teleflex Incorporated
Via Business Wire
News headline image
3 Unprofitable Stocks We Steer Clear Of
Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. Finding... 
Via StockStory
News headline image
Teleflex Initiates Enrollment in Global BIOMAG™‑III Pivotal Trial of Freesolve™ Resorbable Magnesium Scaffold
From Teleflex Incorporated
Via Business Wire
News headline image
Surgical Equipment & Consumables - Specialty Stocks Q1 Recap: Benchmarking Teleflex (NYSE:TFX)
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the surgical equipment & consumables - specialty stocks, including Teleflex (NYSE:TFX) ... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
Four‑Year BIOMAG™-I Study Results Presented at EuroPCR Confirm Long‑Term Safety and Sustained Performance of the Freesolve™ Resorbable Magnesium Scaffold (DREAMS 3G)
From Teleflex Incorporated
Via Business Wire
News headline image
3 Reasons to Sell TFX and 1 Stock to Buy Instead
Teleflex trades at $132.09 per share and has stayed right on track with the overall market, gaining 9.6% over the last six months. At the same time, the S&P ... 
Via StockStory
Topics Stocks
News headline image
Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering
From Teleflex Incorporated
Via Business Wire
News headline image
Teleflex Incorporated Announces Private Offering of $500 Million of Senior Notes Due 2032
From Teleflex Incorporated
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >